Track topics on Twitter Track topics that are important to you
What stops doctors from prescribing your brand? It may be more than one thing
Market barriers affect over 20% of growth hormone prescriptions in the US, and most brands lose market share because of them. According to the endocrinologists we surveyed, that's a problem with no single solution; many of them experience as many as 3 different barriers with any given brand.
Find out which barriers cost your brand the most market share, which competitors are taking it from you, and what you can do to win it back, in Market Access Impact: GHD US.
Based on a survey of 100 adult and paediatric endocrinologists, the report covers 7 major therapies from Aeterna Zentaris, Eli Lilly, EMD Serono, Ferring, Novo Nordisk, Pfizer, Roche, and Sandoz. Handy graphs and charts show you how 7 barriers affect your market share, revealing which competitors you gain share from, and lose it to.
Insight into 7 Major GHD Treatments
Exploring Market Access Barriers
Market Access Impact: GHD US explores key issues affecting drug manufacturers. You'll learn:
How barriers affect market access:
How barriers affect your brand:
A Report Based on Expert Knowledge
We surveyed 100 USbased adult and paediatric endocrinologists, chosen from the largest community of validated physicians in the world
All respondents have:
We conducted the survey between May 2nd and 10th, 2017.
MONEY BACK GUARANTEE!
At FirstWord, we stand behind our reports. If you're not completely satisfied, we'll refund your money. Guaranteed.
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering uptotheminute pharma news, insight, analysis and expert views of importance to your company's success.
FirstWord Reports deliver timely, needtoknow intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.NEXT ARTICLE
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...